POLOCAINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Polocaine, and what generic alternatives are available?
Polocaine is a drug marketed by Dentsply Pharm and Fresenius Kabi Usa and is included in seven NDAs.
The generic ingredient in POLOCAINE is levonordefrin; mepivacaine hydrochloride. There are two drug master file entries for this compound. Additional details are available on the levonordefrin; mepivacaine hydrochloride profile page.
Summary for POLOCAINE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 7 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 100 |
Patent Applications: | 5,077 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for POLOCAINE |
DailyMed Link: | POLOCAINE at DailyMed |
Pharmacology for POLOCAINE
Drug Class | Amide Local Anesthetic |
Physiological Effect | Local Anesthesia |
Anatomical Therapeutic Chemical (ATC) Classes for POLOCAINE
US Patents and Regulatory Information for POLOCAINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dentsply Pharm | POLOCAINE | mepivacaine hydrochloride | INJECTABLE;INJECTION | 088653-001 | Aug 21, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Fresenius Kabi Usa | POLOCAINE-MPF | mepivacaine hydrochloride | INJECTABLE;INJECTION | 089409-001 | Dec 1, 1986 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Dentsply Pharm | POLOCAINE W/ LEVONORDEFRIN | levonordefrin; mepivacaine hydrochloride | INJECTABLE;INJECTION | 089517-001 | Apr 14, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |